![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 5, 3437-3445, January 31, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From In the present study, we have determined
the nature and the kinetics of the cellular events triggered by the
exposure of cells to non-fibrillar amyloid-
Apoptotic Neuronal Cell Death Induced by the Non-fibrillar
Amyloid-
Peptide Proceeds through an Early Reactive
Oxygen Species-dependent Cytoskeleton Perturbation*
§¶,
§,
,
,
,
,
,
, and
**
INSERM EMI 0014, Université de Nancy I,
54505 Vandoeuvre, France and
INSERM U-505, Université
de Paris 6, 75006 Paris, France
peptide (A
). When
cortical neurons were treated with low concentrations of soluble A
(1-40), an early reactive oxygen species
(ROS)-dependent cytoskeleton disruption precedes caspase
activation. Indeed, caspase activation and neuronal cell death were
prevented by the microtubule-stabilizing drug taxol. A perturbation of
the microtubule network was noticeable after being exposed to A
for
1 h, as revealed by electron microscopy and immunocytochemistry.
Microtubule disruption and neuronal cell death induced by A
were
inhibited in the presence of antioxidant molecules, such as probucol.
These data highlight the critical role of ROS production in
A
-mediated cytoskeleton disruption and neuronal cell death. Finally,
using FRAP (fluorescence recovery after photo bleaching) analysis, we observed a
time-dependent biphasic modification of plasma membrane
fluidity, as early as microtubule disorganization. Interestingly,
molecules that inhibited neurotubule perturbation and cell death did
not affect the membrane destabilizing properties of A
, suggesting
that the lipid phase of the plasma membrane might represent the
earliest target for A
. Altogether our results convey the idea that
upon interaction with the plasma membrane, the non-fibrillar A
induces a rapid ROS-dependent disorganization of the
cytoskeleton, which results in apoptosis.
*
This work was supported in part by INSERM and by a grant
from the Aventis French Network on Molecular Mechanism in Alzheimer's disease.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
B. Zhang, Y. Dong, G. Zhang, R. D. Moir, W. Xia, Y. Yue, M. Tian, D. J. Culley, G. Crosby, R. E. Tanzi, et al. The Inhalation Anesthetic Desflurane Induces Caspase Activation and Increases Amyloid {beta}-Protein Levels under Hypoxic Conditions J. Biol. Chem., May 2, 2008; 283(18): 11866 - 11875. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, Y. Dong, U. Maeda, R. D. Moir, W. Xia, D. J. Culley, G. Crosby, and R. E. Tanzi The Inhalation Anesthetic Isoflurane Induces a Vicious Cycle of Apoptosis and Amyloid {beta}-Protein Accumulation J. Neurosci., February 7, 2007; 27(6): 1247 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. King, H.-M. Kan, P. W. Baas, A. Erisir, C. G. Glabe, and G. S. Bloom Tau-dependent microtubule disassembly initiated by prefibrillar {beta}-amyloid J. Cell Biol., November 20, 2006; 175(4): 541 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fifre, I. Sponne, V. Koziel, B. Kriem, F. T. Y. Potin, B. E. Bihain, J.-L. Olivier, T. Oster, and T. Pillot Microtubule-associated Protein MAP1A, MAP1B, and MAP2 Proteolysis during Soluble Amyloid {beta}-Peptide-induced Neuronal Apoptosis: SYNERGISTIC INVOLVEMENT OF CALPAIN AND CASPASE-3 J. Biol. Chem., January 6, 2006; 281(1): 229 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity J. Cell Biol., April 25, 2005; 169(2): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Michaelis, S. Ansar, Y. Chen, E. R. Reiff, K. I. Seyb, R. H. Himes, K. L. Audus, and G. I. Georg {beta}-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 659 - 668. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |